[225Ac]Ac-Macropa-MUC-16

N/A

Report date: 2025/10/22 13:43:25

Base Information

Drug Name[225Ac]Ac-Macropa-MUC-16

Drug Alias NameN/A

ClassificationRadiation-emitting products > Nuclides > Actinium > 225AcRadiation-emitting products > Radioactive therapeutic agentRadiation-emitting products > Radionuclide Drug Conjugates +[5]

Mechanisms of ActionAnti-Mucin-16

TargetsMucin-16

Therapy Area/IndicationsOvarian NeoplasmsPancreatic Neoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryCanada

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesChu De Quebec-Universite Laval

China Registration ClassN/A

Develop Information

Active CompaniesChu De Quebec-Universite Laval

Inactive CompaniesN/A

Active IndicationsOvarian NeoplasmsPancreatic Neoplasms

Inactive IndicationsN/A

Other Information

ATC CodeN/A